Trusted advisors: Transformative potential

We are an investment firm with more than 25 years of experience backing transformational healthcare and biotech companies.

Polaris by the numbers

  • 400+

    companies funded

  • 100+

    exits

  • 50+

    IPOs

  • 50+

    repeat entrepreneurs

  • 50+

    therapies to market

Groundbreaking expertise

Healthcare

Our healthcare portfolio companies target innovative care delivery models, such as digital health, consumer-centric businesses, patient and provider solutions, and data science and analytics.

Life sciences and biotechnology

Our life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics and genomics.

Portfolio

Building successful outcomes

Building successful outcomes

Our affiliate funds

Polaris Growth Fund

Supporting the growth and expansion of profitable, founder-owned technology companies.

Polaris Innovation Fund

Accelerating the commercial and therapeutic potential of early-stage academic research.

References to specific companies are for illustrative purposes only and do not represent all of the companies recommended for advisory clients. Such references are not intended to be, and should not be interpreted as, recommendations or investment advice. Certain statements may be deemed forward-looking, but any such statements are not guarantees of any future performance and actual results or developments may differ materially from those discussed. There is no guarantee that investment objectives will be achieved or that any particular investment will be profitable. Past performance does not guarantee future results. Where applicable, figures include investments made directly and indirectly by the Polaris Main Funds and may include co-investments with the Polaris Growth Funds and the Polaris Innovation Funds. Please see the complete list of investments here, as well as the Terms of Use for additional information and disclosures.